Target intelligence / Profile preview

Cystic fibrosis transmembrane conductance regulator (CFTR) (CFTR)

Target
CFTR
Molecular classification
Ion channel, ABC transporter
01

Overview

The Cystic fibrosis transmembrane conductance regulator (CFTR) is a plasma membrane glycoprotein composed of 1,480 amino acids forming two transmembrane domains (TMD1 and TMD2), two nucleotide-binding domains (NBD1 and NBD2), and a unique regulatory (R) domain, functioning as an ATP- and phosphorylation-gated anion channel that conducts chloride and bicarbonate ions across epithelial cell membranes in organs such as the lungs, pancreas, and intestines. Encoded by the CFTR gene on chromosome 7q31.2, CFTR operates as a member of the ABC transporter superfamily but uniquely serves as an ion channel rather than an active transporter, with activity requiring PKA-mediated phosphorylation of the R domain (up to six sites) to relieve autoinhibition and ATP binding to NBDs for dimerization and pore opening. Loss-of-function mutations in over 2,000 identified variants (classified into six types based on processing, trafficking, or gating defects) cause cystic fibrosis, the most common lethal genetic disease in Caucasians, leading to mucus accumulation, chronic infections, and organ failure due to impaired anion secretion and dehydration of airway surfaces. Cryo-EM structures of human CFTR reveal conformational changes from a dephosphorylated inward-facing state to a phosphorylated ATP-bound outward-open state, with TM8 breaks facilitating gating and specific residues lining the positively charged pore. Therapeutically, CFTR modulators like ivacaftor (potentiator), lumacaftor/tezacaftor/elexacaftor (correctors), and combinations (e.g., Trikafta) target specific mutations (e.g., F508del, G551D), dramatically improving lung function and survival in ∼90% of patients, though challenges persist for rare mutations and complete correction.

Other names
CFTR gene productABC-C7ABCC7
02

Mechanism of action

Potentiation of channel gating (increases open probability in phosphorylated state), Correction of protein folding and trafficking defects (Class II mutations), Stabilization of NBD dimer and promotion of conformational changes for anion conduction

03

Biological functions

Anion transport (chloride and bicarbonate)Channel gating regulated by phosphorylation and ATP
04

Disease associations

Cystic fibrosis
05

Safety considerations

Liver enzyme elevations (hepatotoxicity)Drug-induced liver injuryCataracts (pediatric monitoring)Respiratory adverse events during initiationDrug interactions via CYP3A inhibition/induction
06

Interacting drugs

Ivacaftor

5 more in the full profile.

07

Biomarkers

CFTR gene mutations (e.g., F508del for Class II, G551D for Class III)Nasal potential differenceIntestinal current measurementSweat chloride test

Beyond the preview

Go deeper on Cystic fibrosis transmembrane conductance regulator (CFTR) (CFTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystic fibrosis transmembrane conductance regulator (CFTR) (CFTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call